# MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers

> **NCT04647240** · PHASE2 · RECRUITING · sponsor: **Merakris Therapeutics** · enrollment: 80 (estimated)

## Conditions studied

- Venous Stasis Ulcer
- Venous Leg Ulcer

## Interventions

- **BIOLOGICAL:** MTX-001 (human amniotic fluid)

## Key facts

- **NCT ID:** NCT04647240
- **Lead sponsor:** Merakris Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-26
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647240, "MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04647240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*